Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration

• Moreno Menghini ,

  Contributed equally to this work with: Moreno Menghini, Barbara Kloeckener-Gruissem

  * E-mail: moreno@menghini.biz

  Affiliation Department of Ophthalmology, University Hospital of Zurich, Zurich, Switzerland

  ⨯
• Barbara Kloeckener-Gruissem ,

  Contributed equally to this work with: Moreno Menghini, Barbara Kloeckener-Gruissem

  Affiliations Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland, ETH Zurich, Institute of Biology, Zurich, Switzerland

  ⨯
• Johannes Fleischhauer,

  Affiliation Department of Ophthalmology, University Hospital of Zurich, Zurich, Switzerland

  ⨯
• Malaika M. Kurz-Levin,

  Affiliation Department of Ophthalmology, University Hospital of Zurich, Zurich, Switzerland

  ⨯
• Florian K. P. Sutter,

  Affiliation Department of Ophthalmology, University Hospital of Zurich, Zurich, Switzerland

  ⨯
• Wolfgang Berger,

  Affiliations Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland, Neuroscience Center Zurich (ZNZ), University of Zurich, Zurich, Switzerland, Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland

  ⨯
• Daniel Barthelmes

  Affiliations Department of Ophthalmology, University Hospital of Zurich, Zurich, Switzerland, Save Sight Institute, University of Sydney, Sydney, Australia

  ⨯